Navigation Links
Arena Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2012 Financial Results
Date:11/6/2012

74622,7276,253  Total revenues

1,4853,45925,65110,643Operating ExpensesCost of manufacturing services

1.3961,5572,8396,215Research and development

11,61914,97840,16545,616General and administrative

7,3926,02918,96318,996Restructuring charges

0003,467Amortization of acquired technology & other intangibles

168197517819  Total operating expenses

20,57522,76162,48475,113Interest and Other Income (Expense)Interest income

412081102Interest expense

(1,804)(3,211)(7,324)(11,087)Gain (Loss) from valuation of derivative liabilities

5,259(233)(13,886)387Loss on extinguishment of debt

00(6,338)(10,514)Other

73(10)10340  Total interest and other income (expense), net

3,569(3,434)(27,364)(21,072)Net loss

(15,521)(22,736)(64,197)(85,542)Deemed dividend related to beneficial conversion

  feature of convertible preferred stock

00(2,824)(2,260)Net loss allocable to common stockholders

$(15,521)$(22,736)$(67,021)$(87,802)Net loss per share allocable to common stockholders:Basic

$
(0.07)$
(0.16)$
(0.35)$
(0.64)Diluted

$
(0.07)$
(0.16)$
(0.35)$
(0.64)Shares used in calculating net loss per share allocable

to common stockholders:Basic

213,881145,965189,545136,860Diluted

213,881145,965189,545136,860Arena Pharmaceuticals, Inc.Condensed Consolidated Balance Sheet Data(In thousands)September 30, 2012December 31, 2011(unaudited)1Assets  Cash and cash equivalents

$ 165,774$ 57,632  Accounts receivable

672607  Inventory

2,8080  Prepaid expenses & other current assets

4,4392,021  Land, property & equipment, net

76,03082,066  Acquired technology & other non-current assets

14,43714,803Total assets

$ 264,160$ 157,129Liabilities and Stockholders'
'/>"/>

SOURCE Arena Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Arena Pharmaceuticals to Host Corporate Update and Financial Results Conference Call and Webcast on Tuesday, November 6
2. Arena Pharmaceuticals to Present at the UBS Global Life Sciences Conference
3. Arena Pharmaceuticals to Present at Upcoming Investor Conferences
4. Arena Pharmaceuticals Announces Second Quarter 2012 Financial Results and Recent Developments
5. Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Thursday, August 9
6. Arena Pharmaceuticals Files Marketing Authorization Application in Switzerland for Lorcaserin as a Treatment for Weight Control
7. Arena Pharmaceuticals to Present at the Seventh Annual JMP Securities Healthcare Conference
8. Arena Pharmaceuticals Promotes Craig M. Audet to Executive Officer as Senior Vice President, Operations and Head of Global Regulatory Affairs
9. Aperture Health, Inc., Targeting the Strong Growth in the Long Term Disease Management arena
10. Arena Pharmaceuticals Announces Exercise in Full of Over-Allotment Option and Completion of Public Offering of Common Stock
11. Arena Pharmaceuticals Announces Proposed Public Offering of Common Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2015)... , May 21, 2015 ... the addition of the "Market Assessment of ... report to their offering. ,     (Logo: http://photos.prnewswire.com/prnh/20130307/600769) ... the respiratory imaging diagnostics market in ... Europe . The service provides detailed analysis ...
(Date:5/21/2015)... , May 21, 2015  CryoLife, Inc. (NYSE: ... company focused on cardiac and vascular surgery, announced today ... cash dividend for the second quarter 2015 of $0.03 ... dividend of $0.03 per share will be paid on ... as of June 12, 2015.  The ex-dividend date for ...
(Date:5/21/2015)... 21, 2015  (MUSE Booth # 1510)What:Automating continuous ... (EHR) is invaluable in any hospital setting, but ... a requirement and mainstream in healthcare, the integration ... EHR is gaining traction in MEDITECH facilities.During MUSE ... Site Project Manager & Clinical Analyst at McLaren ...
Breaking Medicine Technology:United States and Europe Respiratory Diagnostics Market Assessment 2015 2CryoLife Announces Quarterly Cash Dividend for the Second Quarter 2015 2Hospital Streamlines ICU Efficiency with Timely Data Integration 2Hospital Streamlines ICU Efficiency with Timely Data Integration 3
(Date:5/22/2015)... LINCOLN, R.I. (PRWEB) May 22, 2015 Memorial ... so Amica Insurance is offering some tips to ... National Safety Council, there will be 383 traffic fatalities this ... tips from the National Highway Traffic Safety Association: , ... everyone in the vehicle is wearing a seatbelt, whether they’re ...
(Date:5/22/2015)... (PRWEB) May 22, 2015 According to ... hub for drug related death, totaling almost 2,500 confirmed drug ... reported by state officials, totals 2,489 deaths stemming from legal ... out, Pennsylvania loses seven people every day to fatal overdoses ... been singled out as one of the most rife with ...
(Date:5/22/2015)... A Phase 3 French study, which ... Clinical Oncology (ASCO)’s annual meeting at the end ... patients who received bevacizumab in addition to the ... Genentech, Inc.) is an antibody that blocks angiogenesis ... used to treat many other cancers, including lung ...
(Date:5/22/2015)... NY (PRWEB) May 22, 2015 Steven ... Housing, Marc Zuluaga, has been selected by Consulting-Specifying Engineer ... The award winners are featured in the May/June issue ... 40 building industry professionals age 40 and younger who ... building community, as well as in other areas of ...
(Date:5/22/2015)... Maine (PRWEB) May 22, 2015 ... single-use swabs for the medical, diagnostic, environmental, and ... entire line of products in the US. At ... their operations outside the US, Puritan remains committed ... products at their Guilford, Maine facility. , Since ...
Breaking Medicine News(10 mins):Health News:Amica Has 4 Road Safety Tips for Memorial Day Weekend 2Health News:Philadelphia Ranks Among the Tops Cities in Penn. for Drug Deaths 2Health News:Mesothelioma Research Organization Excited About Imminent Improvement to Standard of Care 2Health News:Steven Winter Associates’ Marc Zuluaga Earns Innovative Engineering Award 2Health News:Maine Swab Company Celebrates 96 Years of American-made Products 2
... study conducted at Dartmouth Medical School in Hanover, New Hampshire ... old people is normal//, yet this could be one of ... ,Dr. Andrew Saykin and his associates with the help ... who suffered memory loss without dementia, another 40 patients with ...
... sight to watch kids comfortably settled in a beanbag, hastily ... blankly// at a television or computer screen. At a time ... are seen opting for laidback activities. ,Parents, ... marring good habit formation, as children emulate parents in their ...
... it is natural for a patient to tread carefully, ... be overriding emotions// after a heart attack, which cannot ... the occasion to allay the doubts and uncertainties that ... ,Often, ambiguous communication from caregivers cause more harm ...
... relies on the direct, linear relationship between the sequence ... In fact, colinearity of DNA and protein sequences is ... genetic code. However, a paper published today in Science ... global Ludwig Institute for Cancer Research (LICR) and the ...
... high school, Katherine Coit had brain surgery to remove an ... brain.// ,The potentially life-threatening condition called arterio-venous malformation ... with numbness in her mouth and in one of her ... percent of the AVM during a craniotomy three years ago, ...
... many college students left the comforts of home to live ... from mom and dad may be great, but dorm-life// also ... that can be picked up in communal bathrooms/showers. “Shared showers ... bacteria because the wet, steamy atmosphere is a great place ...
Cached Medicine News:Health News:Protein Splicing Upsets the DNA Colinearity Paradigm 2Health News:Gamma Knife Offers Noninvasive Treatment for Vascular Disorders, Brain Tumors 2Health News:Gamma Knife Offers Noninvasive Treatment for Vascular Disorders, Brain Tumors 3Health News:Tips for Avoiding Foot Fungus in Communal Bathrooms 2
... and CVA for CELL-DYN are assayed linearity ... calibration and to verify patient reportable range ... kits also measure the linear performance of ... kits have customized ranges appropriate for each ...
... is a nucleated red blood cell (nRBC) control ... Coulter LH 750/LH 755 hematology analyzer in its ... for the Coulter LH 750/LH 755. nRBC-Chex for ... cap-pierceable vials. nRBC-Chex for LH has a 75-day ...
... negative whole blood control to test for ... tests and hemoglobin electrophoresis. Sickle-Chex is compatible ... solubility kits. Sickle-Chex is packaged in a ... dispenses an accurate sample volume. No pipeting ...
... Proprietary EX.P.R.T. Release Technology ... No stent shortening,, Unique anatomically designed ... the carotid bifurcation,, 0.014 Rapid Exchange ... profile and flexible atraumatic tip,, Radiopaque ...
Medicine Products: